Exalenz Bioscience Ltd. expanded its BreathID Hp urea breath testing product line by introducing the new BreathID Hp Lab system at the recent 2017 annual scientific meeting of the American Association for Clinical Chemistry (AACC) in San Diego. The BreathID Hp systems are intuitive and time-efficient products that detect active carcinogenic H. pylori bacterial infection. Building on the success and technology of the point-of-care BreathID Hp, the new BreathID Hp Lab system provides an automated solution for batch test analysis. Building on this clinically proven diagnostic technology, the BreathID Hp Lab system was engineered with today’s laboratories and clinics in mind by intuitively automating lab operations that maximize lab throughput and management, minimize human error, and provide cost-effectiveness. With H. pylori – a known Group 1 carcinogen – continuing to be the world’s most common bacterial infection causing many gastrointestinal issues, the imperative need of laboratories to provide physicians a clinically proven – yet cost-effective and accurate diagnostic solution for H. pylori testing – is met with the simple-to-use but clinically powerful BreathID Hp Lab system.